analyst
DN
NASDAQ · DNLI
Denali Therapeutics Inc.
Healthcare · Biotechnology
$18.74
Down-$0.15 (-0.79%)
Updated Nov 15, 2026, 12:28 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -6
- Dividend yield
- 0.00%
- 52-week range
- $15.34 – $27.30
- Volume
- 795.68K
- Avg. volume
- 1.72M
Price performance · DNLI
DNLI price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
DNLI closed at $18.74 after 20 trading sessions, up 3.88% for the selected period.
- Last close
- $18.74
- Period change
- +3.88%
- Period low
- $18.04
- Period high
- $20.96
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $18.77 | $19.005 | $18.34 | $18.74 | 795.68K |
| Nov 12, 2026 | $19.39 | $19.60 | $18.795 | $18.89 | 1.31M |
| Nov 11, 2026 | $19.905 | $20.24 | $19.625 | $19.73 | 873.56K |
| Nov 10, 2026 | $20.01 | $20.69 | $19.72 | $19.85 | 975.85K |
| Nov 9, 2026 | $20.34 | $20.5579 | $19.7601 | $20.33 | 1.38M |
| Nov 6, 2026 | $19.97 | $20.36 | $19.78 | $20.07 | 1.59M |
| Nov 5, 2026 | $20.96 | $21.08 | $19.65 | $19.72 | 2.25M |
| Nov 4, 2026 | $21.23 | $22.19 | $19.75 | $20.96 | 4.9M |
| Nov 3, 2026 | $19.21 | $19.52 | $18.98 | $19.45 | 2.43M |
| Nov 2, 2026 | $19.11 | $19.195 | $18.32 | $18.86 | 1.24M |
| Oct 30, 2026 | $19.25 | $19.635 | $18.635 | $18.94 | 1.31M |
| Oct 29, 2026 | $19.35 | $19.78 | $19.14 | $19.32 | 1.45M |
| Oct 28, 2026 | $18.92 | $19.29 | $18.84 | $19.29 | 1.59M |
| Oct 27, 2026 | $18.48 | $19.32 | $18.40 | $19.22 | 1.48M |
| Oct 26, 2026 | $18.495 | $18.67 | $18.35 | $18.66 | 726.05K |
| Oct 23, 2026 | $18.49 | $18.50 | $18.005 | $18.41 | 1.01M |
| Oct 22, 2026 | $18.53 | $18.94 | $18.44 | $18.66 | 816.75K |
| Oct 21, 2026 | $18.93 | $19.13 | $18.58 | $18.68 | 1.43M |
| Oct 20, 2026 | $18.10 | $19.35 | $17.945 | $18.93 | 1.82M |
| Oct 19, 2026 | $17.61 | $18.36 | $17.33 | $18.04 | 2.69M |
Latest DNLI news
The latest Smart Investors Daily articles mentioning DNLI.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…